Form 4 Filing for Actinium Pharmaceuticals, Inc.

Ajit Shetty, a director at Actinium Pharmaceuticals, Inc., acquired 61,600 shares of Common Stock on September 2, 2026. This acquisition was part of a grant of restricted stock units (RSUs) that vest over three years. Additionally, Shetty was granted 92,400 stock options with an exercise price of $1.00, which vest monthly starting from the grant date and expire on September 2, 2036. Following these transactions, Shetty directly owns 62,357 shares of Common Stock and holds 92,400 exercisable stock options.